MedTrace Logo

Is Eovist Suitable for Arterial-Phase MR Imaging of Liver

NCT02684526 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2016-12-16

No results posted yet for this study

Summary

To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.

Conditions

Interventions

PROCEDURE

Eovist Contrast

Subjects will undergo an MRI (magnetic resonance imaging) scan using the Eovist contrast agent. This MRI scan takes approximately 45minutes to 1 hour to complete.

PROCEDURE

Non Eovist Contrast

Subjects will undergo an MRI (magnetic resonance imaging) scan using a contrast agent other than Eovist. This MRI scan takes approximately 45minutes to 1 hour to complete.

Sponsors & Collaborators

Principal Investigators

  • Hero Hussain, M.D. · University of Michigan

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-08-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02684526 on ClinicalTrials.gov